Compugen Ltd. appointed Oliver Froescheis, Ph.D., as senior VP, corporate and business development.
AlzeCure Pharma AB appointed Martin Jönsson as the company’s new CEO.
Jim Wassil was appointed chief operating officer of SutroVax.
Stuart Hughes was named CEO of Pathios Therapeutics Ltd.
Jaydev Thakkar was named chief operating officer and Milan Shah was appointed chief technology officer of Biofourmis
Miles D. White will step down as CEO of Abbott on March 31, 2020, after a 21-year tenure, the second longest for a non-founder in today’s S&P 100.
Paul V. Campanelli, president and CEO of Endo International plc, in November 2019 notified the company’s board of directors of his intention to retire.
Roche Diagnostics Corporation appointed Matthew Sause as president and CEO, North America, effective November 4, 2019.
Peter Heerma was appointed chief commercial officer of Retrophin Inc.
ADC Therapeutics SA appointed Jennifer Herron as chief commercial officer, effective Nov. 4, 2019.
